Extending Mendelian Risk Prediction Models to Handle Misreported Family History

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute Department of Biostatistics, Harvard School of Public Health, Boston, MA, USA. Faculty of Industrial Engineering and Management, TechnionIsrael Institute of Technology, Haifa, Israel. Division of Cancer Epidemiology and Genetics, Biostatistics Branch, National Cancer Institute, Bethesda, MD, USA. Department of Epidemiology, University of California Irvine, Irvine, CA, USA.

[1]  K. Sweet,et al.  Identification and referral of families at high risk for cancer susceptibility. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  D. Evans,et al.  False family history of breast cancer in the family cancer clinic. , 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[3]  Hormuzd A Katki,et al.  Effect of Misreported Family History on Mendelian Mutation Prediction Models , 2006, Biometrics.

[4]  Giovanni Parmigiani,et al.  PancPRO: risk assessment for individuals with a family history of pancreatic cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  M. King,et al.  Genetic epidemiology of breast and ovarian cancers. , 1997, Epidemiologic reviews.

[6]  M. Slattery,et al.  Comparison of self-reported and database-linked family history of cancer data in a case-control study. , 1997, American journal of epidemiology.

[7]  H. Anton-Culver,et al.  Validation of family history of breast cancer and identification of the BRCA1 and other syndromes using a population‐based cancer registry , 1996, Genetic epidemiology.

[8]  Validity of Models for Predicting BRCA1 and BRCA2 Mutations , 2007, Annals of Internal Medicine.

[9]  D. Easton,et al.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.

[10]  J. Stockman,et al.  Prediction of Germline Mutations and Cancer Risk in the Lynch Syndrome , 2008 .

[11]  G. Vlastos,et al.  Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  G. Parmigiani,et al.  Multiple diseases in carrier probability estimation: Accounting for surviving all cancers other than breast and ovary in BRCAPRO , 2008, Statistics in medicine.

[13]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[14]  Mitchell H Gail,et al.  Confirmation of family cancer history reported in a population-based survey. , 2011, Journal of the National Cancer Institute.

[15]  R. Croyle,et al.  Risk communication in genetic testing for cancer susceptibility. , 1999, Journal of the National Cancer Institute. Monographs.

[16]  H. Murff,et al.  Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. , 2004, JAMA.

[17]  Giovanni Parmigiani,et al.  Familial Cancer Risk Assessment Using BayesMendel , 2010 .

[18]  D. Evans,et al.  The accuracy of diagnoses as reported in families with cancer: a retrospective study , 1999, Journal of medical genetics.

[19]  D. Seminara,et al.  Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[20]  Argyrios Ziogas,et al.  Validation of family history data in cancer family registries. , 2003, American journal of preventive medicine.

[21]  H Campbell,et al.  GPs' views on their role in cancer genetics services and current practice. , 1999, Family practice.

[22]  Karl W Broman,et al.  BayesMendel: an R Environment for Mendelian Risk Prediction , 2004, Statistical applications in genetics and molecular biology.

[23]  D. Stoppa-Lyonnet,et al.  Genetic testing for breast cancer predisposition. , 1999, Surgical Clinics of North America.

[24]  Andrew W. Roddam,et al.  Measurement Error in Nonlinear Models: a Modern Perspective , 2008 .

[25]  Ramana V. Davuluri,et al.  Biomedical Informatics for Cancer Research: Springer , 2010 .

[26]  Giovanni Parmigiani,et al.  BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.